FindTrial
Sign In

A novel pancreaticojejunostomy technique in preventing pancreatic leakage and hemorrhage after pancreatoduodenectom

A novel pancreaticojejunostomy technique in preventing pancreatic leakage and hemorrhage after pancreatoduodenectom

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030561
Enrollment
Unknown
Registered
2020-03-07
Start date
2020-07-01
Completion date
Unknown
Last updated
2020-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periampullary tumors

Interventions

Experimental group:novel pancreaticojejunostomy technique
control group:conventional end-to-side pancreatic duct-to-mucosa anastomosis

Sponsors

Xiaodong Tan
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Patients with periampullary tumors indicated by at least two imaging examinations or pathological biopsy before surgery; (2) Men and women aged >=18 years; (3) Provision of written informed consent by patients or their legal guardians.

Exclusion criteria

Exclusion criteria: (1) Extensive tumor metastasis; (2) Abnormal blood coagulation; (3) Renal dysfunction (creatinine>250 µmol/L); (4) Chronic liver disease; (5) History of radiation therapy; (6) American Society of Anesthesiologists (ASA) class IV-V; (7) Life expectancy < 48 hours; (8) Lactating or pregnant women; and (9) Participation in other drug clinical trials.

Design outcomes

Primary

MeasureTime frame
Incidence of pancreatic fistula;Incidence of postoperative hemorrhage;Surgical indicators;—

Secondary

MeasureTime frame
Incidence of delayed gastric emptying;Economic indicators;—

Countries

China

Contacts

Public ContactXiaodong Tan

Shengjing Hospital of China Medical University

tanxdcmu@163.com+86 18940255168

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026